FTC Protects Consumers by Requiring Valeant to Sell Three Prescription Drugs as Condition to Acquire Rival Dermatology Businesses from Sanofi and Johnson & Johnson
Date
Protecting competition in the market for three topical dermatology drugs, the Federal Trade Commission has approved orders requiring Valeant Pharmaceuticals International, Inc. to divest three drugs...